Loading…
Advances in pharmacology and chemotherapy. Volume 14 /
ADV IN PHARMACOLOGY & CHEMOTHERAPY VOL 14.
| Call Number: | Libro Electrónico |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | Inglés |
| Published: |
New York :
Academic Press,
1977.
|
| Series: | Advances in pharmacology and chemotherapy ;
v. 14 |
| Subjects: | |
| Online Access: | Texto completo |
Table of Contents:
- Cover; Contents; Chapter 1. Chemotherapy of Schistosomiasis mansoni; I. Introduction; II. Laboratory Maintenance of Schistosoma mansoni; III. Drug Testing in Vitro; IV. Drug Testing in Vivo; V. Preclinical Trials; VI. Clinical Trials; VII. Antischistosomal Drugs in Clinical Use; VIII. Compounds with Antischistosomal Activity; References; Chapter 2. The Behavioral Toxicity of Monoamine Oxidase-Inhibiting Antidepressants; I. Introduction; II. Methods; III. Iproniazid-Related Adverse Behavioral Changes; IV. Phenelzine-Related Adverse Behavioral Changes
- v. Tranylcypromine-Related Adverse Behavioral ChangesVI. Adverse Behavioral Changes Associated with Other Monoamine Oxidase-Inhibiting Antidepressants; VII. Comparison of Adverse Behavioral Effects during Monoamine Oxidase Inhibitor Treatment with Those during Treatment with Other Antidepressant Drugs; VIII. Behavioral Effects of Monoamine Oxidase-Inhibiting Drugs in Animals of Possible Relevance to Their Behavioral Toxicity in Man; IX. Biochemical Effects of Monoamine Oxidase-Inhibiting Drugs in Animals and Man of Possible Relevance to Their Behavioral Effects; X. Discussion and Conclusions
- v. Excretion of Persorbed ParticlesVI. Breakdown of Persorbed Particles; VII. Discussion; VIII. Future Developments; IX. Conclusion; References; Chapter 6. Pharmacological Control of the Synthesis and Metabolism of Cyclic Nucleotides; I. Introduction; II. Adenylate Cyclase; III. Guanylate Cyclase; IV. Cyclic Nucleotide Phosphodiesterases; V. Transport of Cyclic AMP; VI. Inhibition of Action of Cyclic AMP; VII. Directions of Future Research in Pharmacological Control of Cyclic Nucleotides; VIII. Clinical Implications; IX. Concluding Remarks; References